[go: up one dir, main page]

PE20050476A1 - Compuestos de pirrol y pirazol - Google Patents

Compuestos de pirrol y pirazol

Info

Publication number
PE20050476A1
PE20050476A1 PE2004000971A PE2004000971A PE20050476A1 PE 20050476 A1 PE20050476 A1 PE 20050476A1 PE 2004000971 A PE2004000971 A PE 2004000971A PE 2004000971 A PE2004000971 A PE 2004000971A PE 20050476 A1 PE20050476 A1 PE 20050476A1
Authority
PE
Peru
Prior art keywords
pirrol
alkyl
pirazole
compounds
schizophrenia
Prior art date
Application number
PE2004000971A
Other languages
English (en)
Inventor
Pamela Ann Albaugh
Mansanet Ana Maria Castano
Esteban Dominguez-Manzanares
Jian Eric Hong
William Joseph Hornback
Larry Gene Huffman
Dennis Michael Zimmerman
William David Miller
Paul Leslie Orsntein
Michelle Lee Thompson
Eric George Tromiczak
Zhipei Wu
Hamideh Zarrinmayeh
Delu Jiang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20050476A1 publication Critical patent/PE20050476A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A COMPUESTOS DE PIRROL Y PIRAZOL A SUS SALES FARMACEUTICAS DE FORMULA I Y II DONDE X ES N, CR1; R ES H, METILO, ETILO, ENTRE OTROS; R1 ES H, F, I, CHO, ENTRE OTROS; A ES OH, NO2, NH2, ENTRE OTROS; Z ES O-ALQUILO C1-C6, NH-ALQUILO C1-C6, O-ALQUENILO C2-C4, ENTRE OTROS. TAMBIEN REFERIDA A COMPOSICIONES QUE SON UTILES EN EL TRATAMIENTO DE LA ESQUIZOFRENIA, DEFICIENCIAS COGNITIVAS ASOCIADAS A ESQUIZOFRENIA, ENFERMEDAD DE ALZHEIMER, DEPRESION, ENTRE OTRAS
PE2004000971A 2003-10-08 2004-10-06 Compuestos de pirrol y pirazol PE20050476A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03380224 2003-10-08
US53779404P 2004-01-20 2004-01-20

Publications (1)

Publication Number Publication Date
PE20050476A1 true PE20050476A1 (es) 2005-08-24

Family

ID=34524773

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000971A PE20050476A1 (es) 2003-10-08 2004-10-06 Compuestos de pirrol y pirazol

Country Status (9)

Country Link
EP (1) EP1670757B1 (es)
AR (1) AR049417A1 (es)
AT (1) ATE430729T1 (es)
CA (1) CA2541458C (es)
DE (1) DE602004021011D1 (es)
ES (1) ES2324044T3 (es)
PE (1) PE20050476A1 (es)
TW (1) TW200526574A (es)
WO (1) WO2005040110A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2601098C (en) 2005-03-16 2011-07-05 Aventis Pharmaceuticals Inc. Dipyrazoles as central nervous system agents
TWI446908B (zh) * 2005-06-06 2014-08-01 Lilly Co Eli Ａｍｐａ受體強化劑
TW200817385A (en) 2006-07-04 2008-04-16 Organon Nv Heterocyclic derivatives
DE102007007605A1 (de) 2007-02-13 2008-08-14 J. Eberspächer GmbH & Co. KG Brennstoffzellensystem
JP2010143826A (ja) * 2007-04-12 2010-07-01 Mitsui Chemicals Inc ３−アミノチオフェン誘導体の製造方法
WO2009054789A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5
WO2009054791A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5
WO2009054792A1 (en) * 2007-10-26 2009-04-30 Astrazeneca Ab Aminopyridine derivatives as modulators of mglur5
TW200922586A (en) * 2007-10-26 2009-06-01 Astrazeneca Ab Thiophene 1,2,4-triazole derivatives as modulators of mGluR5
TW200934497A (en) 2007-11-13 2009-08-16 Organon Nv Heterocyclic derivatives
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
WO2010009029A2 (en) * 2008-07-15 2010-01-21 Wyeth Methods for the preparation of azole compounds
KR101724293B1 (ko) 2009-02-25 2017-04-07 다케다 야쿠힌 고교 가부시키가이샤 피롤 화합물의 제조 방법
WO2010115952A1 (en) 2009-04-09 2010-10-14 N.V. Organon Indane derivatives
JP5580423B2 (ja) * 2009-09-29 2014-08-27 アルベマール・コーポレーシヨン ３−（メチルチオ）チオフェンを生成する過程
EP2604602A4 (en) * 2010-08-11 2013-12-18 Taisho Pharmaceutical Co Ltd HETEROARYL PYRAZOLE DERIVATIVE
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
JP2014062047A (ja) * 2011-01-21 2014-04-10 Taisho Pharmaceutical Co Ltd ピラゾール誘導体
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
PT2953942T (pt) 2013-02-06 2018-01-17 Bayer Cropscience Ag Derivados de pirazol substituídos com halogéneo como agentes pesticidas
EP2961746B1 (en) 2013-02-28 2018-01-03 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
KR102367319B1 (ko) * 2013-11-27 2022-02-23 바이엘 애니멀 헬스 게엠베하 5-플루오로-1h-피라졸의 제조 방법
TWI678362B (zh) * 2013-11-27 2019-12-01 德商拜耳動物保健有限公司 用於製備５-氟-１ｈ-吡唑之方法（二）
WO2015101622A1 (de) 2014-01-03 2015-07-09 Bayer Cropscience Ag Neue pyrazolyl-heteroarylamide als schädlingsbekämpfungsmittel
WO2016026789A1 (en) 2014-08-19 2016-02-25 Bayer Cropscience Aktiengesellschaft Process for the preparation of 5-fluoro-1h-pyrazoles starting from hexafluoropropene
AU2016231174B2 (en) 2015-03-10 2020-09-10 Bayer Animal Health Gmbh Pyrazolyl-derivatives as pest control agents
BR112018069001B1 (pt) * 2016-03-31 2022-09-06 Sumitomo Chemical Company, Limited Composto heterocíclico e composição e método para controlar o artrópode nocivo
US10662157B2 (en) 2016-04-06 2020-05-26 Sumitomo Chemical Company, Limited Heterocyclic compound
CN111393348B (zh) * 2020-04-24 2023-03-28 黑龙江大学 一种氮位取代苯基吡咯类化合物及其在植物杀菌中的用途
CN113831280B (zh) * 2021-11-01 2023-08-15 上海埃农生物科技有限公司 一种啶酰菌胺的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776954A (en) * 1996-10-30 1998-07-07 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
PE20000942A1 (es) * 1998-07-31 2000-09-28 Lilly Co Eli Derivados de amida, carbamato y urea

Also Published As

Publication number Publication date
CA2541458C (en) 2011-09-20
CA2541458A1 (en) 2005-05-06
EP1670757A1 (en) 2006-06-21
TW200526574A (en) 2005-08-16
DE602004021011D1 (de) 2009-06-18
EP1670757B1 (en) 2009-05-06
AR049417A1 (es) 2006-08-02
ATE430729T1 (de) 2009-05-15
WO2005040110A1 (en) 2005-05-06
ES2324044T3 (es) 2009-07-29

Similar Documents

Publication Publication Date Title
PE20050476A1 (es) Compuestos de pirrol y pirazol
PE20040636A1 (es) Ester de 2'-c-metil-3'-o-l-valina de ribofuranosilcitidina
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
UY30300A1 (es) Compuestos triarílicos y sus derivados
UY26958A1 (es) Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación
UY27918A1 (es) Derivados de benzodioxol
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
PE20120505A1 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
CR9954A (es) Derivados de pirazina
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
PE20050484A1 (es) Composicion farmaceutica de liberacion sostenida
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
AR028914A1 (es) 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3
SE0301446D0 (sv) New Compounds
TN2009000483A1 (fr) Derives de 7-alkynyl-1-8-naphthyridones, leur preparation et leur application en therapeutique
PA8576001A1 (es) "difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion , medicamentos que comprenden estos compuestos y su uso".
PA8482001A1 (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson adhd y microadenomas
UY28848A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos
UY27786A1 (es) Derivados de isoquinolina.
PA8589801A1 (es) Aminoalcoxiindoles
PA8581201A1 (es) Nuevos derivados de tiazol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal